Neuroendocrine Tumours and Therapy
Creator:   Editorial Office
Created:   1/18/2011
Contains:  78 items
A collections of articles from the NMC archive looking at neuroendocrine tumours and their therapy.

1 2 3 4 5

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

Giammarile, Francesco; Billotey, Claire; Lombard-Bohas, Catherine; More

Nuclear Medicine Communications . 32(2):91-97, February 2011.

Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide

Barone, Raffaella; Walrand, Stéphan; Konijnenberg, Mark; More

Nuclear Medicine Communications . 29(3):283-290, March 2008.

Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy

Stathaki, Maria I.; Koutroubakis, Ioannis E.; Koukouraki, Sophia I.; More

Nuclear Medicine Communications . 29(1):27-32, January 2008.

Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours

Ambrosini, Valentina; Tomassetti, Paola; Rubello, Domenico; More

Nuclear Medicine Communications . 28(6):473-477, June 2007.

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

Savelli, Giordano; Lucignani, Giovanni; Seregni, Ettore; More

Nuclear Medicine Communications . 25(5):445-449, May 2004.

Radioimmunometric assay of B‐type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection

HERVÁS, I.; ALMENAR, L.; PÉREZ-PASTOR, J. L.; More

Nuclear Medicine Communications . 24(8):925-931, August 2003.

1 2 3 4 5